Tell us about your career journey and what led you to SciLeads?
My path to SciLeads has been shaped by a career spent at the intersection of data, product strategy, and innovation across the life sciences and technology sectors. Looking back, the beginning of my professional journey in life sciences and healthcare global operations and transformations at Thomson Reuters was the start. Then I joined Clarivate, where I spent six years leading major life sciences SaaS and data portfolios and ultimately serving as Vice President of Product Management and Strategy. I continued to deepen my expertise in real-world data, diagnostics, and commercialisations as Head of Product Management at
Diaceutics. This combination of scientific background, data-intensive product leadership, and experience scaling complex platforms ultimately led me to SciLeads.
Tell us about your role as Chief Product Officer, and what you find most rewarding?
As the Chief Product Officer, I’m responsible for defining our product vision, guiding the strategic direction of our platform, and ensuring that we deliver solutions that truly support our commercial teams across the life sciences sector. My role involves working closely with our product, engineering, and data organisation to translate market needs and customer feedback into a clear, actionable roadmap that drives both innovation and measurable value. The past 18 months have been a particularly dynamic period for SciLeads. We have seen significant growth across our product, engineering, and data teams, bringing in exceptional
talent and expanding our capability to execute at a much faster pace. This growth has enabled us to pursue more ambitious initiatives, strengthen the depth and accuracy of our data intelligence, and deliver an increasingly sophisticated set of tools for our users. What I find most rewarding about the role is the combination of strategic influence and tangible impact. While SciLeads continues to scale rapidly, we have maintained an environment where thoughtful ideas can progress quickly and where collaboration remains at the centre of how we operate. I’m leading a team that is deeply committed to solving complex challenges and elevating how scientific sales teams identify and engage their customers, and that is both an honour and a driving force in my work.
What aspects of the SciLeads product excite you most?
What truly excites me is the way SciLeads brings together research activity, funding movements, and real-time scientific engagement signals into a single platform for commercial teams. While many tools offer contact information or basic prospecting leads, SciLeads goes much further by surfacing why an opportunity matters when it is emerging and how it aligns with a company’s ideal customer profile. This capability is already transforming how our customers operate, and we are only just scratching the surface of what we can do as we continue to invest in our new features and market-leading insights.
What does the future hold for the SciLeads product?
We’re not just pulling isolated data points. We will be connecting publications, grants, conference behaviour, lab activities, and purchasing intent indicators into a cohesive narrative that will help sales teams prioritize with far greater accuracy and, importantly, help pharma companies stay ahead of their competition in understanding the biotech landscape. This reduces guesswork, shortens sales cycles, and enables companies to focus on making the right commercial decision at the right time. Being part of building this intelligence layer is incredibly exciting because it is an area where SciLeads will truly lead the market. We are solving a problem that competitors typically treat as an afterthought, not just finding high-value prospects and commercial targets, but identifying them ahead of time and therefore giving our clients the competitive edge.